Holen Sie sich die Stockscreener-App
16.25
0.43%
-0.07
Handel nachbörslich:
16.25
Schlusskurs vom Vortag:
$16.32
Offen:
$16.27
24-Stunden-Volumen:
160.28K
Relative Volume:
1.15
Marktkapitalisierung:
$199.15M
Einnahmen:
$1.54M
Nettoeinkommen (Verlust:
$-38.70M
KGV:
-3.4797
EPS:
-4.67
Netto-Cashflow:
$-36.86M
1W Leistung:
+11.23%
1M Leistung:
+71.05%
6M Leistung:
+180.17%
1J Leistung:
-13.06%
1-Tages-Spanne:
$15.93
$16.60
1-Wochen-Bereich:
$13.40
$16.97
52-Wochen-Spanne:
$4.64
$20.77
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Firmenname
Corbus Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
617-963-0103
Adresse
500 RIVER RIDGE DRIVE, NORWOOD, MA
Vergleichen Sie CRBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
16.25 | 200.01M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy |
| 2025-02-28 | Eingeleitet | William Blair | Outperform |
| 2024-12-02 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-30 | Eingeleitet | Wedbush | Outperform |
| 2024-07-22 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-06-26 | Eingeleitet | B. Riley Securities | Buy |
| 2024-06-03 | Bestätigt | Oppenheimer | Outperform |
| 2024-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-06 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-09-08 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-07-07 | Eingeleitet | ROTH Capital | Buy |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-03-26 | Eingeleitet | Nomura | Buy |
| 2019-04-05 | Eingeleitet | Jefferies | Buy |
| 2019-03-20 | Eingeleitet | Oppenheimer | Outperform |
| 2019-01-11 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-12-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-10-24 | Eingeleitet | B. Riley FBR | Buy |
| 2018-01-19 | Eingeleitet | Raymond James | Outperform |
| 2017-12-14 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-11-08 | Bestätigt | Noble Financial | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-03-30 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Bestätigt | JMP Securities | Mkt Outperform |
| 2016-11-11 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten
Corbus Pharmaceuticals (CRBP) to Showcase Updated Clinical Data at ESMO 2025 - GuruFocus
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 - GlobeNewswire
Can Corbus Pharmaceuticals Holdings Inc. stock maintain operating marginsQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com
Visual analytics tools that track Corbus Pharmaceuticals Holdings Inc. performanceAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
How hedge fund analytics apply to Corbus Pharmaceuticals Holdings Inc. stockJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Best data tools to analyze Corbus Pharmaceuticals Holdings Inc. stockMarket Growth Summary & Precise Swing Trade Alerts - newser.com
CRBP stock touches 52-week low at $9.26 amid market challenges - MSN
How Corbus Pharmaceuticals Holdings Inc. (3371) stock valuation compares with sectorTrade Performance Summary & Community Verified Watchlist Alerts - newser.com
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. lossesMarket Trend Report & Reliable Entry Point Alerts - newser.com
How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockDay Trade & Weekly Market Pulse Updates - newser.com
How sentiment analysis helps forecast Corbus Pharmaceuticals Holdings Inc.Earnings Recap Summary & Growth-Oriented Investment Plans - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsQuarterly Portfolio Summary & Weekly High Potential Alerts - newser.com
What analysts say about Corbus Pharmaceuticals Holdings Inc 3371 stockBull Market Opportunities & Free Real-Time Trading Signals - earlytimes.in
Can Corbus Pharmaceuticals Holdings Inc. (3371) stock deliver strong annual returnsMarket Performance Report & Verified Short-Term Plans - newser.com
Is Corbus Pharmaceuticals Holdings Inc. reversing from oversold territoryTake Profit & Long-Term Capital Growth Strategies - newser.com
Can Corbus Pharmaceuticals Holdings Inc. hit a new high this monthAnalyst Upgrade & Proven Capital Preservation Methods - newser.com
Is a relief rally coming for Corbus Pharmaceuticals Holdings Inc. holdersQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock reversal real or fakeJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Corbus Pharmaceuticals' (CRBP) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews
Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium - GlobeNewswire
Oct 9 Fireside Chat 10:00AM ET — Corbus CEO Yuval Cohen to Present at Piper Sandler Virtual Oncology Symposium - Stock Titan
What analysts say about Corbus Pharmaceuticals Holdings Inc stockMarket Capitalization Trends & Affordable Trading Growth - earlytimes.in
Corbus Pharmaceuticals Holdings Inc. stock outlook for YEARAnalyst Upgrade & Safe Entry Zone Tips - newser.com
Published on: 2025-10-05 06:30:04 - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock gaining market share2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-05 03:14:17 - newser.com
Published on: 2025-10-05 02:56:16 - newser.com
Institutional scanner results for Corbus Pharmaceuticals Holdings Inc.Portfolio Value Summary & Growth Focused Stock Pick Reports - newser.com
These Are The 3 Top-Rated Cannabis Stocks To Buy As Trump Backs CBD - Barchart.com
Oppenheimer lowers Corbus Pharmaceuticals stock price target ahead of ESMO data - Investing.com Canada
What drives Corbus Pharmaceuticals Holdings Inc 3371 stock priceTrade Execution Strategies & Exceptional Growth Investment - earlytimes.in
Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Above 50-Day Moving AverageTime to Sell? - MarketBeat
Published on: 2025-09-29 15:28:09 - newser.com
Published on: 2025-09-29 13:16:49 - newser.com
Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Altmeyer Anne | Director |
May 30 '25 |
Sale |
7.25 |
1,392 |
10,096 |
1,391 |
| Smethurst Dominic | Chief Medical Officer |
Mar 06 '25 |
Sale |
6.78 |
6,393 |
43,330 |
70,807 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):